JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Saturday, March 1, 2025

Who really needs a second COVID booster? Here’s what to know

by

1067 days ago
20220330
FILE - Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

FILE - Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

 

By LAU­RAN NEER­GAARD-As­so­ci­at­ed Press

 

Many Amer­i­cans now can get a sec­ond COVID-19 boost­er, but it’s hard to tell who re­al­ly needs an­oth­er shot right now and who could wait.

The Food and Drug Ad­min­is­tra­tion au­tho­rized ex­tra Pfiz­er or Mod­er­na shots for any­one 50 or old­er and for some younger peo­ple with se­vere­ly weak­ened im­mune sys­tems. It’s an ef­fort to get ahead of a pos­si­ble next coro­n­avirus surge.

With COVID-19 cas­es low in the U.S., it’s easy to ig­nore calls for an­oth­er dose — or for those who aren’t yet vac­ci­nat­ed or boost­ed to get up to date, said Dr. Er­i­ca John­son, an in­fec­tious dis­ease spe­cial­ist at the Amer­i­can Board of In­ter­nal Med­i­cine.

Her ad­vice: If you’re on the fence, use this lull to talk with your doc­tor about how pro­tect­ed you re­al­ly are — and need to be.

WHO IS EL­I­GI­BLE FOR A SEC­OND BOOST­ER?

Any­one 50 and old­er can get the ex­tra dose at least four months af­ter their last vac­ci­na­tion. So can se­vere­ly im­mune-com­pro­mised pa­tients, such as or­gan trans­plant re­cip­i­ents, as young as 12.

Adults can choose ei­ther the Pfiz­er or the Mod­er­na vac­cine for their ex­tra shot, but Pfiz­er is the on­ly op­tion for chil­dren.

WHAT ABOUT PEO­PLE WHO GOT JOHN­SON & JOHN­SON?

Adults who re­ceived J&J’s sin­gle-dose vac­cine al­ready were el­i­gi­ble for a boost­er of any kind -- and the Cen­ters for Dis­ease Con­trol and Pre­ven­tion rec­om­mends on­ly some of them get an­oth­er.

A new study found a Mod­er­na or Pfiz­er sec­ond shot was su­pe­ri­or to get­ting a sec­ond J&J dose. So the ad­vice is any­one who got a sec­ond J&J shot now can choose a Mod­er­na or Pfiz­er dose.

But if they al­ready had one of those oth­er boost­ers, the CDC says on­ly those who meet the newest cri­te­ria -- age or weak im­mune sys­tem — qual­i­fy for an­oth­er.

WHAT PROMPT­ED THE MOVE?

Vac­cines still of­fer strong pro­tec­tion against se­vere ill­ness and death, but ef­fec­tive­ness against milder in­fec­tions wanes months lat­er. The shots al­so don’t work as well against new vari­ants like the su­per-con­ta­gious omi­cron mu­tant as they did ear­li­er in the pan­dem­ic.

That’s why every­one 12 and old­er, re­gard­less of their health, al­ready was urged to get a first boost­er for the best chance at fend­ing off omi­cron. On­ly about half of those el­i­gi­ble have.

With an omi­cron sib­ling caus­ing spikes in in­fec­tions in oth­er coun­tries, of­fi­cials are ner­vous the U.S. is next, prompt­ing ef­forts to of­fer ex­tra pro­tec­tion to the most vul­ner­a­ble.

WHAT’S THE EV­I­DENCE FOR AN­OTH­ER BOOST­ER?

Many sci­en­tists say it’s lim­it­ed, leav­ing pub­lic health of­fi­cials to use their best judg­ment.

Dur­ing the U.S. omi­cron wave, two Pfiz­er or Mod­er­na dos­es plus a boost­er were 94% ef­fec­tive against death or need­ing a ven­ti­la­tor, ac­cord­ing to a re­cent CDC study. That pro­tec­tion was low­est — 74% — in im­mune-com­pro­mised peo­ple, al­though most hadn’t got­ten the al­ready rec­om­mend­ed third dose.

Is­rael be­gan of­fer­ing peo­ple 60 and old­er a sec­ond boost­er dur­ing its omi­cron surge. Pre­lim­i­nary find­ings post­ed on­line last week show there were few­er deaths among peo­ple who chose an­oth­er boost­er com­pared to those who skipped the fourth dose.

The FDA de­cid­ed to set the age lim­it at 50 in­stead of 60 be­cause that’s when chron­ic ill­ness­es like heart dis­ease or di­a­betes be­come more com­mon, leav­ing peo­ple more vul­ner­a­ble to se­ri­ous COVID-19.

WHO RE­AL­LY NEEDS A SEC­OND BOOST­ER?

The CDC says an ex­tra shot is an op­tion — but those most like­ly to ben­e­fit are those most vul­ner­a­ble to se­vere dis­ease, in­clud­ing peo­ple 65 and old­er and 50-some­things who have mul­ti­ple health prob­lems.

WHEN SHOULD I GET IT?

Again, ex­perts have dif­fer­ing opin­ions, part­ly be­cause it’s not clear how long any ex­tra ben­e­fit lasts.

“We can nev­er re­al­ly per­fect­ly time when the next wave is, or when some­one might en­counter in­fec­tion,” said John­son, who sees pa­tients at Johns Hop­kins Bayview Med­ical Cen­ter in Bal­ti­more. “To be as ready as pos­si­ble, I think every­one just needs to stay as up to date as pos­si­ble with their vac­cines.”

An­oth­er dose now may make sense for old­er peo­ple and the im­mune-com­pro­mised, but “there’s less ur­gency in an oth­er­wise healthy per­son,” said Uni­ver­si­ty of Penn­syl­va­nia im­mu­nol­o­gist E. John Wher­ry.

At 50, Wher­ry said he’s healthy enough to watch if cas­es rise enough to prompt an­oth­er boost­er, but he’d pre­fer to wait un­til fall. That’s be­cause go­ing longer be­tween vac­ci­na­tions al­lows the im­mune re­sponse to bet­ter ma­ture and strength­en.

 

 

COVID-19PfizerCovid BoosterModerna


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored